Wave Life Sciences, Inc. (WVE)
4.86
+0.16
(+3.40%)
USD |
NASDAQ |
Sep 04, 16:00
4.855
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Total Liabilities (Quarterly) : 104.80M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 104.80M |
| March 31, 2026 | 71.81M |
| December 31, 2025 | 112.27M |
| September 30, 2025 | 108.96M |
| June 30, 2025 | 105.22M |
| March 31, 2025 | 108.67M |
| December 31, 2024 | 134.82M |
| September 30, 2024 | 208.99M |
| June 30, 2024 | 204.42M |
| March 31, 2024 | 202.01M |
| December 31, 2023 | 227.44M |
| September 30, 2023 | 232.53M |
| June 30, 2023 | 273.83M |
| March 31, 2023 | 294.11M |
| December 31, 2022 | 183.60M |
| September 30, 2022 | 178.16M |
| June 30, 2022 | 174.50M |
| March 31, 2022 | 159.54M |
| December 31, 2021 | 166.64M |
| September 30, 2021 | 162.74M |
| June 30, 2021 | 176.70M |
| March 31, 2021 | 181.95M |
| Date | Value |
|---|---|
| December 31, 2020 | 188.59M |
| September 30, 2020 | 193.95M |
| June 30, 2020 | 200.57M |
| March 31, 2020 | 209.84M |
| December 31, 2019 | 212.64M |
| September 30, 2019 | 224.56M |
| June 30, 2019 | 217.45M |
| March 31, 2019 | 225.88M |
| December 31, 2018 | 214.72M |
| September 30, 2018 | 210.10M |
| June 30, 2018 | 206.57M |
| March 31, 2018 | 32.50M |
| December 31, 2017 | 34.36M |
| September 30, 2017 | 28.36M |
| June 30, 2017 | 37.52M |
| March 31, 2017 | 26.55M |
| December 31, 2016 | 22.07M |
| September 30, 2016 | 20.96M |
| June 30, 2016 | 16.19M |
| March 31, 2016 | 4.127M |
| December 31, 2015 | 4.059M |
| September 30, 2015 | 74.12M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.29M |
| CorMedix, Inc. | 443.22M |
| Eloxx Pharmaceuticals, Inc. | 16.97M |
| Cannabis Global, Inc. | 6.178M |
| Breakthrough Chemistry, Inc. | 0.4631M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 558.32M |
| Shareholders Equity (Quarterly) | 453.52M |
| Debt to Equity Ratio | 0.0961 |
| Current Ratio | 9.987 |
| Net Debt Paydown Yield | -0.36% |